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Abstract
Chemokines are members of a large family of chemotactic cytokines that signal through
their receptors to mediate leukocyte recruitment during inflammation and homeostasis. The
chemokine receptor CXCR2 has largely been associated with neutrophil recruitment. However,
there is emerging evidence of roles for chemokines and their receptors in processes other than
leukocyte migration. We have previously demonstrated that CXCR2 knockout (KO) mice have
thinner skin compared to wild-type mice. Herein we demonstrate that this is due to a thinner
subcutaneous adipose layer, as a result of fewer and smaller individual adipocytes. We observe
a similar phenotype in other fat depots and present data that suggests this may be due to reduced
expression of adipogenesis related genes associated with adipocyte specific CXCR2 signaling.
Interestingly, this phenotype is evident in female, but not male, CXCR2 KO mice. These findings
expand our understanding of nonleukocyte related chemokine receptor functions and help to
explain some previously observed adipose-related phenotypes in CXCR2KOmice.
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1 INTRODUCTION
Chemokines belong to a family of approximately 50 structurally
related proteins that signal through their cognate G-protein coupled
receptors (GPCRs) to mediate cellular migration and recruitment.1
Chemokine receptors are expressed on leukocytes at rest and during
inflammation and play an important role in the multistep process of
leukocyte migration from the circulation, across the endothelium and
within tissues.2 Chemokine activity is also fine-tuned by a subfamily
of receptors called atypical chemokine receptors (ACKRs), which are
stromally expressed and that regulate local chemokine presentation
and availability.3 Given their central role in leukocyte recruitment,
chemokines and their receptors are integral to the immune response
and thus inflammatory based diseases.4 The chemokine system has
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therefore been a target for therapeutic intervention in inflammatory
disease. However, there has been limited success in this regard5,6
and this is thought to be at least partially due to our lack of basic
understanding of the breadth and complexity of chemokine function.6
Chemokines and their receptors also play a key role in homeostatic
processes. For example, the CXCR4 receptor and its ligand CXCL12
are critical to retention and maturation of hematopoietic stem cells
in the bone marrow7 and other homeostatic chemokine receptors
are central contributors to cellular address codes ensuring precise
temperospatial leukocytemigration under resting conditions.6 In addi-
tion to their involvement in regulating cellular migration in immune
and inflammatory responses chemokines and their receptors, in
association with the ACKRs, display evidence of significant pleiotropy
contributing to the regulation of processes such as angiogenesis,8
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cellular proliferation,9 and apoptosis.10 Chemokines, their receptors,
and the ACKRs also play key roles in development including govern-
ing stem cell migration within the embryo and contributing to the
regulation of branchingmorphogenesis.11,12
CXCR2 is a chemokine receptor that has largely been associated
with expression, and function, on neutrophils during inflammatory
responses. Along with its ligands CXCL1-3 and CXCL5-8, CXCR2
controls neutrophil release from the bone marrow13 and enables
their recruitment to inflamed and infected sites.14,15 An additional,
noncanonical CXCR2 ligand, MIF, has also been identified and is
thought to play a role in recruitment of myelomonocytic cells during
atherosclerosis.16,17 Given the role of neutrophils in propagating
inflammatory disease CXCR2 is seen as a viable therapeutic target in
a range of pathologies,18 for example, chronic obstructive pulmonary
disease (COPD)19 and chronic pancreatic inflammation.20 Further-
more, CXCR2 blockade is also suggested to be of potential use in can-
cer therapydue to its ability to prevent recruitment of pro-tumorigenic
myeloid derived suppressor cells to the tumormicroenvironment.21,22
We have previously demonstrated that adult female CXCR2 knock-
out (KO) mice have thinner skin than wild-type (WT) mice.23 Here
we present data explaining the basis for this phenotype. Specifically
we show that CXCR2 KO female mice have smaller adipocytes in
several different fat depots, possibly because of aberrant expression
of CXCR2-regulated adipogenesis related genes.24 Our findings may,
at least in part, explain CXCR2 KO mouse protection from obesity-
induced insulin resistance.25 Overall the results presented broaden
our understanding of the role of the chemokine system in adipose
tissue regulation and add to the developmental processes in which
chemokines play a role.
2 MATERIALS AND METHODS
2.1 Mice
CXCR2 KO15 (backcrossed for at least 12 generations onto the
C57/Bl6 background) and WT mice were bred in a specific pathogen-
free environment and fed a normal lab diet (ad libitum) in the animal
facility of the Beatson Institute for Cancer Research and were used at
the indicated age, juvenile (6 wk) and adult (8-12 wk), in accordance
with the animal care and welfare protocols approved by the animal
welfare and ethical review board at the University of Glasgow. The
observed phenotype described herein was also confirmed to be
present in littermates. All experiments were performed under the
auspices of a United KingdomHomeOffice project license.
2.2 Histology
Skin and fat depots were harvested from mice, fixed in formalin, pro-
cessed, and embedded in paraffin wax. A 5-𝜇m-thick tissue sections
were cut from these paraffin blocks, baked (65◦C for 30 min) onto
SuperFrost slides (Thermo Scientific, Waltham, MA, USA), dewaxed in
xylene, rehydrated, and stained with H&E counterstain. Finally, slides
were dehydrated andmounted using DPX (Leica,Wetzlar, Germany).
Myeloperoxidase (neutrophil) and von Willebrand factor (vWF)
staining was undertaken by the Diagnostic services unit, School of
Veterinary Medicine at the University of Glasgow. Astra blue (Mast
cell) and MAC2 (macrophage) staining was undertaken as described
in detail previously.23 The indicated measurements were then taken
from blinded samples using the Zen software platform (Zeiss,
Oberkochen, Germany).
2.3 Flow cytometry
Skin and fat depots were harvested from resting WT or CXCR2 KO
mice, digested and then analyzed for leukocyte content using flow
cytometry. Lower dorsal skin for shaved mice was dissected, cut into
small pieces, and digested in HBSS containing DNase I (100 𝜇g/ml),
collagenase D (1 mg/ml), and dispase II (500 𝜇g/ml) (Roche, Basel,
Switzerland) for 90 min with shaking at 37◦C. FBS (20 𝜇l) was added
to neutralize enzymes and homogenates were filtered through 70 𝜇m
filters and washed in PBS. Inguinal and perigonadal adipose tissue was
digested as described elsewhere.12
Single cell suspensions prepared from digested tissues or in vitro
adipocyte cultures were washed into PBS, stained with fixable via-
bility solution (eBioscience, Thermo Scientific) and blocked with FcR
reagent (Miltenyi Biotech, Gladbach, Germany). Suspensions were
then washed into PBS containing 1 mM EDTA and 1% FBS (FACS
buffer) (Sigma-Aldrich, St. Louis,MO,USA) and stainedwith antibodies
diluted 1:200 in FACS buffer (CD45, F4/80 (eBioscience, Thermo
Scientific), CD11b, Ly6G, CD117 (Biolegend, San Diego, CA, USA),
Siglec F (BD Biosciences, Franklin Lakes, NJ, USA), and CXCR2 (R & D
Systems, Minneapolis, MN, USA)). Samples were fixed and analyzed
using a Fortessa flow cytometer (BD Biosciences) based within the
Institute of Infection, Immunity and Inflammation flow cytometry core
facility at the University of Glasgow.
2.4 Adipocyte differentiation, stimulation,
and analysis
The 3T3-L1 fibroblast cell line (a gift from Professor Gwyn Gould,
University of Glasgow) was differentiated as described elsewhere,26
briefly cells were cultured in DMEMwith 10% FCS at 37◦C in 5%CO2.
To induce differentiation, cells were grown to confluence before addi-
tion of differentiation medium (DMEM containing 10% FBS (Gibco,
Thermo Scientific), 5 𝜇M troglitazone (Tocris, Bristol, United King-
dom), 1 𝜇g/ml insulin (Sigma-Aldrich), 0.5 mM IBMX (Sigma-Aldrich),
and 0.25𝜇MDexamethasone (Sigma-Aldrich). After 3 days culture, the
media was changed to DMEM containing 10% FBS, 5 𝜇M troglitazone,
and 1 𝜇g/ml Insulin. Following a further 3 days of culture, media was
changed to DMEM containing 10% FBS only and then changed every
2 days. Cells were analyzed 10 days after initiation of differentiation.
Differentiation was also undertaken in the presence of the CXCR2
inhibitor 1 (SB 332235) or CXCR2 inhibitor 2 (SB 225002) (10 𝜇M)
(Tocris) to determine its effect on this process. Oil Red-O staining was
used to confirm differentiation. Media was aspirated and cells washed
with phosphate buffered saline before fixation in 10% formalin solu-
tion for 1 h. Monolayers were incubated with 60% Isopropanol for
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TABLE 1 Primer sequences for qPCR analysis
GENES Sequence
PPAR𝛾 Forward 5’-GCCTATGAGCACTTCACAAGA-3’
Reverse 5’-ATCACGGAGAGGTCCACAGA-3’
GAPDH Forward 5’-CAGCAAGGACACTGAGCAAG-3’
Reverse 5’-TATTATGGGGGTCTGGGATG -3’
CXCR2 Forward 5’-TGTCTGCTCCCTTCCATCTT-3’
Reverse 5’-CCATTTCCTCTCCTCCAGCT-3’
FABP4 Forward 5’-AAATCACCGCAGACGACAGG-3’
Reverse 5’-GCTTGTCACCATCTCGTTTTCT-3’
18S Forward 5’-GACTCAACACGGGAAACCTC- 3’
Reverse 5’-TAACCAGACAAATCGCTCCAC -3’
2 min before staining with Oil Red-O solution for 5 min and washing
with water. Finally, cells were counterstained with hematoxylin and
washed before imaging using an EVOS FL automicroscope (Invitrogen,
Carlsbad, NM, USA). Cell size and lipid area were calculated from
acquired images using FIJI software.27 Quantification of Oil Red-O
staining was undertaken as described previously,24 following fixation
cells were washed with water and stained with 0.5% Oil Red-O
(w/v) in isopropanol for 15 min. Cells were washed with water to
remove excess dye before Oil Red-O was eluted with isopropanol and
quantified (OD540) relative to blank wells.
Western blot analysis of cell cultures lysed in RIPA buffer (Thermo
Scientific)wasundertakenasdescribedelsewehere24 using anantiper-
oxisome proliferator-activated receptor gamma (PPAR𝛾) antibody
(Cell Signaling Technologies, Danvers, MA, USA) and an anti-GAPDH
antibody (Cell Signaling Technologies).
2.5 PCR and qRT-PCR analysis
Samples from fat depotswereharvested andbriefly stored inRNAlater
(Invitrogen) at −80◦C. RNA was then extracted from these samples
using Qiazol and physically disrupted by shaking with ball bearings
in a Tissue Lyser LT (Qiagen, Hilden, Germany) at 50 oscillations per
second for 10 min. The fluid phase was transferred to a clean tube and
centrifuged at 4◦C, 10,000 RCF for 15 min. The fluid phase was aspi-
rated and transferred to a fresh tube prior to standard RNA extraction
using the miRNeasy extraction kit (Qiagen). Purified RNA (500 ng)
was converted to cDNA using the high capacity RNA to cDNA kit
(Thermo Scientific).
cDNA was analyzed for CXCR2 expression using the indicated
primers (Table 1), Q5 High-Fidelity DNA polymerase and DNTP
mix (NewEngland Biolabs, Ipswich, MA, USA) using a standard
thermocycler programme. The resulting products were “run” on a
2% agarose gel containing ethidium bromide and the gel analyzed
using an Alpha Imager (Alpha Innotech, San Leandro, CA, USA),
following electrophoresis.
For qRT-PCR, cDNA was analyzed using the indicated primers
(Table 1) and SYBR Green FastMix (Quanta bio, Beverley, MA, USA)
in a QuantoStudio 7 flex machine (Life Technologies, Carlsbad, NM,
USA) and compared to standards for each gene, using the indicated
primer sets.28 Absolute copy number for each samplewas then plotted
relative to a house keeping gene control.
2.6 Statistical analysis
Data sets containing only two groups were initially analyzed for nor-
mal distribution (KS normality test) and equal variance (F test) using
GraphPad Prism software. Normally distributed data with equal vari-
ance were analyzed using an unpaired Student’s t test, normally dis-
tributed data with unequal variance were analyzed using an unpaired
t test with Welch’s correction and nonnormally distributed data with
equal variance were analyzed using a Mann-Whitney test. Data sets
containing more than two groups that were all normally distributed
were analyzed using a one-way ANOVAwith Tukey’s multiple compar-
ison test and data sets containing more than two groups that were not
all normally distributed were analyzed using a one-way ANOVA with
Kruskal-Wallis comparison.Where datawere deemed significantly dif-
ferent (P < 0.05) actual P values are provided in the figures from the
indicated statistical test.
2.7 Online supplemental material
Supplemental Fig. 1. Western blot images for PPAR𝛾 and GAPDH
expression analysis in differentiated adipocytes, CXCR2 expression on
undifferentiated and differentiated cells and viability of cells cultured
in the absence or presence of vehicle or CXCR2 inhibitors.
3 RESULTS
3.1 Smaller adipocytes are associatedwith a thinner
subcutaneous adipose layer in female CXCR2KO,
compared toWT,mice
As reported in a previous study, and as shown in Fig. 1, we observed
that female CXCR2 KO mice have thinner skin.23 Gross histologic
(Fig. 1Ai) and quantitative assessment (Fig. 1Aii) of subcutaneous
adipose layer thickness in WT and CXCR2 KO female mice revealed
that this reduced skin thickness is specifically associatedwith a thinner
adipocyte layer and no significant differences in epidermal or dermal
thickness were noted (data not shown). High power magnification
revealed that the adipocytes in the CXCR2 KO mouse subcutaneous
adipose layer were typically smaller than those in WT adipose tissues
(Fig. 1Bi) and this was confirmed by measuring the size of individual
adipocytes in the CXCR2 KO and WT mice which showed the CXCR2
KO adipocytes to be significantly (P = 0.0021) smaller in size than the
WT cells (Fig. 1Bii). In addition to reduction in size, the CXCR2 KO
mouse adipose layer contained fewer cells as assessed by counting
cells per field of view (Fig. 1C). Overall therefore, these data show
that female CXCR2 KO mice have a thinner adipose layer than WT
mice and that this relates to smaller, and fewer, adipocytes within the
CXCR2KO adipose layer.
3.2 Adipocytes frommultiple tissue sources are
smaller in CXCR2KOmice
Visual analysis of the anterior subcutaneous (tricep-associated),
inguinal and perigonadal white adipose tissue (WAT) reveals that
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F IGURE 1 Female CXCR2 KOmice have a thinner subcutaneous adipose layer due to fewer and smaller adipocytes. Skin was dissected from
adult female mice before processing and H&E staining of sections from wild-type and CXCR2 KO mice. (A) (i) Brightfield microscopy was used
to take images of the skin (scale bars: 50 𝜇m) and (ii) thickness of the adipocyte layer was systematically measured. (B) (i) the subcutaneous adi-
pose depot was further imaged at high magnification (scale bars: 20 𝜇m) and (ii) the size of individual adipocytes measured and expressed as 𝜇m2.
(C) In addition, the number of individual adipocytes contained in the adipocyte layer (per field of view; FOV) was quantified. Data are plotted as
mean (±SEM) (Aii and Bii) or (±SD) (C) from one experiment containing at least 5 mice in each group, representative of at least 2 separate experi-
ments. Each symbol represents an individual mouse. Data were analyzed with an unpaired t test withWelch’s correction (i), unpaired t test (ii) and
aMann-Whitney test (iii)
reduced size of adipose depots in CXCR2 KO mice appears to be
wide spread (Fig. 2A). Closer histologic analysis of tricep-associated,
perigonadal, and inguinal adipose depots in CXCR2 KOmice revealed,
again, that smaller depots were associated with reduced adipocyte
size (Fig. 2B) and quantitative analysis revealed this to be a significant
(P = 0.0026, 0.0011, or 0.003, respectively) reduction (approximately
50%) at eachof these tissue sites (Fig. 2Ci, 2Cii, and2Ciii). Interestingly,
CXCR2 heterozygous (het) null female mice display haploinsufficiency
in adipocyte size in the inguinal adipose depots, but not in perigonadal
and tricep-associated adipose tissue (Fig. 2C).
Nonquantitative PCR (Fig. 2D) revealed that cells in all the WT fat
depots expressed CXCR2 mRNA and that it was completely absent in
the CXCR2KOmice.
3.3 Reduced adipose tissue size is seen in female,
but notmale, CXCR2KOmice
Our initial analyses were performed using female mice. To investigate
any potential gender specificity of this phenotype, adult male CXCR2
KOmice were also analyzed, in comparison toWTmice. In contrast to
female mice, CXCR2 KO male mice showed no significant differences
in subcutaneous adipose thickness or adipocyte size in skin, inguinal,
or perigonadal adipose depots. This was apparent on gross histologic
assessment (Fig. 3A) as well as on more detailed quantitative analy-
sis which revealed no significant differences in subcutaneous adipose
layer thickness (Fig. 3B) and no significant difference in adipocyte size
in inguinal or perigonadal sites (Fig. 3Ci and ii). Comparison with the
data from analysis of adipose tissue and adipocytes in female mice
(Fig. 1) suggests that WT females show generally increased subcu-
taneous adipose thickness and greater adipocyte size compared to
males and that CXCR2 KO females have subcutaneous adipose tis-
sue, and adipocytes, of comparable size to those in WT males of the
same age. Taken together these data suggest that CXCR2 plays a role
in regulating adipocyte size in female, but not male, mice in resting
adipose tissue.
qRT-PCR analysis of CXCR2 mRNA expression in male or female
whole skin, tricep WAT, inguinal WAT, or perigonadal WAT demon-
strated that the highest expression was in the whole skin (Fig. 3D).
Female mice express significantly higher levels of CXCR2 mRNA in
their perigonadal adipose tissue, compared tomales.
3.4 The subcutaneous adipose layer fromCXCR2
KOmice contains comparable levels
of myelomonocytic cells toWTmice
The cells traditionally associated with CXCR2 expression, and func-
tion, are neutrophils, which are key players in the inflammatory
response.18 For this reason, and given previous studies describing a
link between adipose tissue regulation, chemokine receptors (CXCR2,
CCR2, or CX3CR1) and inflammation,29–31 we determined the
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F IGURE 2 Adipocytes frommultiple sources are smaller in CXCR2KO femalemice, compared towild-types. (A)Mice were dissected to allow
visualization of white adipose tissue (WAT) depots at the indicated sites. (B) WAT was dissected, fixed, and processed from each of these 3 areas
and sections were stained with H&E (scale bars: 50 𝜇m) from wild-type, CXCR2 heterozygous (het), and CXCR2 knockout (KO) mice. (C) The area
occupied by individual adipocytes was calculated and averaged for each individual mouse, data from each mouse was plotted for (i) tricep; (ii)
perigonadal, and (iii) inguinal sites, where each symbol represents an individual mouse. (D) Skin and adipose depots were dissected fromWT and
CXCR2 KOmice and analyzed for CXCR2 expression by nonquantitative PCR as demonstrated by an expected product of 169 base pairs from the
CXCR2 specific primer set. Data from two experiments are pooled and plotted as mean (±SEM). Data were analyzed using an ordinary one-way
ANOVAwith Tukey’s post hoc test (Cii and iii) or with a Kruskal-Wallis test (Ci)
presence of neutrophils, mast cells, macrophages, and vWF positive
blood vessels within the subcutaneous adipose layer of the skin ofWT
and CXCR2 KO female mice (Fig. 4). As expected, myeloperoxidase
staining clearly demonstrated the complete absence of neutrophils in
the subcutaneous adipose tissue of CXCR2 KO mice (Fig. 4A) and this
was seen for both female and male (data not shown) mice. Further-
more, Astra blue, Mac 2, and VWF staining demonstrated no visual
(Fig. 4B, C, and D) or quantitative (Fig. 4E and F) changes in absolute
numbers of mast cells, macrophages and blood vessels, respectively,
betweenWTandCXCR2KOmice. In addition, the ratio ofmast cells, or
macrophages, to adipocytes was unchanged between WT and CXCR2
KO femalemice (Fig. 4F).
Flow cytometric analysis revealed that the only leukocyte popula-
tion expressing CXCR2 from the skin, inguinal adipose, or perigonadal
adipose were skin neutrophils (Fig. 4G). Flow cytometric analysis
of leukocyte content of the skin also revealed no differences in the
levels of neutrophils, macrophages, and eosinophils and a significant
reduction in mast cells in the CXCR2 KO mice (Fig. 4H). Similar
analysis of inguinal and perigonadal adipose tissue demonstrated few
differences in leukocyte levels inWT CXCR2 KOmice. The only signif-
icant change observed was an increase in neutrophil levels in CXCR2
KO perigonadal tissue.
Together, these data suggest that CXCR2 has little effect on leuko-
cyte seeding of the skin, inguinal adipose, and perigonadal adipose
tissue, at rest. Furthermore, alterations in the levels of neutrophils,
mast cells, macrophages, eosinophils, and blood vessels seem unlikely
to explain the difference in subcutaneous adipocyte size betweenWT
and CXCR2KO femalemice.
3.5 Adipocytes express CXCR2, show reduced
mRNA levels of adipogenesis associated genes in
CXCR2KOmice and reduced differentiation in the
presence of a CXCR2 inhibitor
Previous in vitro studies have reported that adipocytes themselves
express CXCR2 and that it plays a role, in combination with its ligands,
in their development and size.24,32–34 To confirm this expression
pattern, we differentiated adipocytes from pre-adipocytes, which was
confirmed by positive oil red-O staining of the differentiated cells
(Fig. 5A). qRT-PCR analysis of these cells pre, and post, adipocyte
differentiation revealed increased expression of CXCR2 in the differ-
entiated cells (Fig. 5B). Flow cytometry revealed that preadipocytes
and differentiated adipocytes express CXCR2 protein (Supplemental
Fig. 1A). Quantification of oil red-O staining demonstrated a signif-
icant reduction in the presence of two different CXCR2 inhibitors
during adipocyte differentiation (Fig. 5C), compared to differenti-
ated cells alone, associated with a reduction of PPAR𝛾 expression
(Fig. 5D and Supplemental Fig. 1B). Inhibitor 2 seemed to show a
greater ability to inhibit adipogenesis; however, this may be associated
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F IGURE 3 CXCR2 KO male mice have no significant change in adipocyte size compared to wild-types. (A) Skin and adipose depots were dis-
sected from adult male mice (>8 wk) before processing and H&E staining of sections from wild-type and CXCR2 KOmice. Brightfield microscopy
was used to take images of the skin, inguinal adipose, or perigonadal adipose tissue (scale bars: 50 𝜇m). (B) Adipose thickness and (C) individual
adipocyte area for (i) inguinal and (ii) perigonadal sites were measured. (D) Quantitative real-time PCR was used to analyze CXCR2 expression
in skin or adipose tissues from male and female mice, relative to the house-keeping gene, GAPDH. Data are plotted as mean (±SEM), where each
symbol represents data from an individual mouse and analyzed using an unpaired t test orWelch’s t test (D), ns= not significant
with its effect on viability of these cells not seen with inhibitor 1
(Supplemental Fig. 1C).
3.6 Adipogenesis-related genes are downregulated
in adipose tissue of CXCR2KOmice
qRT-PCR was next used to investigate relative mRNA expression of
PPAR𝛾 and fatty acid binding protein 4 (FABP4) in inguinal and subcu-
taneous adipose depots. Both of these genes play a key role in adipoge-
nesis and have been shown, in vitro, to be transcriptionally regulated
in response to CXCR2 signaling.24,34 In adult mice (8-12 wk of age) no
significant differences in expression of these genes was observed in
either of these adipose depots (Fig. 6A). However, when mRNA was
extracted fromthe sameadiposedepotsof juvenile (6wkof age) female
mice and analyzed (Fig. 6B) we found that FABP4 showed a small, but
significant (P = 0.0246), reduction in expression in the inguinal fat
depot of these juvenile mice and that there was a 50% reduction in the
levels of PPAR𝛾 mRNA in the skin of juvenile mice (Fig. 6B). Analysis of
inguinal adipocytes from juvenile mice demonstrated that there was
a significant difference in adipocyte size betweenWT and CXCR2 KO
females (Fig. 6C). However, inguinal adipocytes fromWT juvenile mice
(6 wk old) were smaller than those in adults, whereas there was little
difference in adipocyte size between6 and8wk in theCXCR2KOmice
(Figs. 2 and 6C). This suggests that at around 6 wk of age adipocytes in
the inguinal fat depot increase in size during transition to adulthood,
a time period key to inguinal mammary gland maturation,12 and it is
at this stage that CXCR2 may play a role in inguinal adipogenesis. This
would possibly confirm findings from a previous study demonstrating
a role for CXCR2 in adipogenesis at specific points of maturation.24,34
Taken together these data demonstrate that CXCR2 KOmice show
a significant reduction in expression of genes that are key to adipoge-
nesis at 6 wk of age in specific fat depots. The specificity and timing of
adipogenesis-related gene expression suggests that CXCR2 is involved
in the development of different adipose depots at specific phases of
mouse development.
These data, in combination with previous in vitro mechanis-
tic studies,24,29,32,34 demonstrate that CXCR2 plays a key role in
adipogenesis and regulates adipocyte cell and depot size in vivo,
possibly via its direct expression on adipocytes.
4 DISCUSSION
In this study, we have demonstrated a role for the chemokine recep-
tor CXCR2 in adipocyte cell development and thus adipose depots, in
vivo. Our data, in combination with previous detailed mechanistic in
vitro24,32,34 and in vivo29 studies, suggest that the role of CXCR2 in
resting adipose development is due to its expression on adipocytes
themselves, and is therefore independentof neutrophils and theirwell-
characterized pro-inflammatory functions.1 Whereas the full range of
adipogenesis related genes controlled by CXCR2 signaling, and the
phase of maturation at which they function, remain to be determined,
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F IGURE 4 Resting CXCR2 KO mice show limited differences in neutrophil, mast cell, macrophage, eosinophil or blood vessel numbers in
subcutaneous fat. Skin was dissected from adult female mice before processing and staining (scale bars: 50 𝜇m) to detect (A) neutrophils, (B)
mast cells, (C) macrophages, and (D) von Willebrand factor positive vessels from wild-type and CXCR2 KO mice. (E) The numbers of mast cells
(i), macrophages (ii), and blood vessels (iii) were quantified and plotted as the mean number per field of view. (F) (i) Mast cell and (ii) macrophage
numbers were also expressed as ratio of cell number to adipocyte number. (G and H) Flow cytometry was used to analyze leukocyte content
of skin, inguinal WAT, and perigonadal WAT. (G) CXCR2 positive staining in CD45+CD11b+Ly6G+ cells from skin samples. (H) Quantification
of neutrophil (CD45+CD11b+Ly6g+), macrophage (CD45+CD11b+SiglecF-F4/80+), eosinophil (CD45+CD11b+F480+SiglecF+) and mast cell
(CD45+CD117+) content of skin, inguinalWAT, and perigonadalWAT. Data are plotted as mean (±SEM), where each symbol represents data from
an individual mouse and analyzed using an unpaired t test, representative of two separate experiments (A-F), ns= not significant
it is clear that chemokine signaling contributes to the regulation of adi-
pogenesis. This may be in a cell/context specific manner24 mediated
through ERK and JNK phosphorylation24,34 and by the regulation of
expression of adipogenesis-related genes such as PPAR𝛾 and FABP4.
This CXCR2 adipogenesis function represents a novel, and nonin-
flammatory, role for this chemokine receptor and widens our under-
standing of its role in biology. Several other chemokine receptors have
beenassociated, bothdirectly and indirectly,with regulationof adipose
tissue. CCR2 and CX3CR1 have been implicated in adipose regula-
tion via their effects onmacrophage infiltration into adipose tissue and
the subsequent regulatory role of these cells.30,31 CXCR4 is expressed
on adipocytes and limits obesity, demonstrated by CXCR4 adipocyte-
specific KOmice displaying exaggerated high fat diet-induced obesity,
compared to WT mice.35 This study suggested that CXCR4 played a
role in limiting inflammatory cell infiltration into adipose tissue but
also in the thermogenic activity of brown adipose tissue. Addition-
ally, CXCR7 activation has been shown to limit atherosclerosis by
regulation of blood cholesterol.36 Thus, CXCR2 represents one facet
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F IGURE 5 Differentiated adipocytes and fat depots express CXCR2. (A) 3T3-L1 cells were differentiated into adipocytes and cells stainedwith
oil red-O (scale bars: 50 𝜇m). (B) mRNA was extracted before and after differentiation, reverse transcribed to cDNA and analyzed for CXCR2
expression relative to the house-keeping gene 18s. (C) Oil red-O staining was quantified in undifferentiated and differentiated adipocytes in the
absence or presence of two different CXCR2 inhibitors (expressed relative to differentiated cells). (D) Adipocytes differentiated in the absence
and presence of a CXCR2 inhibitor 1 were analyzed for PPAR𝛾 protein expression relative to GAPDH levels (left panel) and quantified relative
to GAPDH using densitometry. Data are plotted as mean (±SEM), where each symbol represents an experimental replicate. Analyzed using an
unpaired t test with Welch’s correction (B and D) or one-way ANOVA with TUKEY’s multiple comparison test (C). Data are representative of two
separate experiments
F IGURE 6 Adipogenesis related genes are down-regulated in the skin and inguinal adipose tissue of juvenile CXCR2 KO mice. mRNA was
extracted from inguinal adipose tissue and the skin of (A) adult and (B) juvenile female wild-type and CXCR2 KOmice and analyzed for expression
of PPAR𝛾 andFABP4 relative to the house-keeping geneGAPDH. (C) Inguinal adipose tissue from juvenilemicewas dissected, fixed, processed, and
sections stained with H&E. The area occupied by individual adipocytes was calculated and plotted. Data are plotted as mean (±SEM) where each
symbol represents data from an individual mouse and analyzed using an unpaired t test. Data are representative of two separate experiments
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of chemokine mediated control of adipose tissue and related dis-
eases; however, it seems to function at rest via direct adipogenesis
effects and not through regulation of inflammatory cells entering into
adipose tissues.
This significant effect on a fundamental process such as adipocyte
development may provide mechanistic clues to previous phenotypes
associated with CXCR2 KO mice. CXCR2 and its ligand CXCL5 are
enriched in human atherosclerotic coronary arteries, where a CXCL5
genetic variant may be a molecular marker and target for treat-
ment in coronary artery disease.37 Furthermore, CXCR2 KO mice
have improved sensitivity to insulin in an obesity induced model of
insulin resistance.25 Given the significant role that adipocytes play in
atherosclerosis and obesity induced insulin resistance38 it seems pos-
sible, though speculative at this stage, that CXCR2mediated adipocyte
differentiationmay play a significant role in these processes.
In summary we have shown that CXCR2 KO mice have smaller
subcutaneous fat depots due to smaller individual adipocytes, a find-
ing similar to adipocytes from other adipose depots. This seems to
be due to reduced expression of key adipogenesis-related genes at
specific time points in the life cycle of the mouse. Our study, there-
fore, reveals an atypical function for CXCR2 and contributes to our
overall understanding of the regulation of adipocity by chemokines
and their receptors.
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